PLK1 and prostate cancer: This liposome showed a significant effect on cell uptake, increasing apoptosis in prostatic cancer cells via preserving the siRNA that reduced polo-like kinase 1 (PLK-1) expression by 22–75% (based on the type of synthesized liposome) [193].